Early Transcatheter Mitral Valve Repair After Myocardial Infarction
Key facts
- Who runs it
- Fundación para la Investigación Biosanitaria del Principado de Asturias
- Where
- Israel, Italy, Netherlands, and Spain32 sites in 4 countriesChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 250 people, planned
- Started
- 24 Dec 2024
- Expected to end
- 16 Jun 2028
- Type of study
- Interventional, 2 groups
- Treatments tested
- Early transcatheter edge-to-edge mitral valve repair (TEER).
- MitraClip
- Optimal medical treatment
- Record updated
- 20 October 2025
Who can take part
- Age
- 18 years to 99 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Patients with symptomatic moderate to severe or severe MR after acute MI
- Age > 18 years
- Based on the following classification recently published in "Transcatheter Mitral Edge-to-Edge Repair for Treatment of Acute Mitral Regurgitation" by M. Shuvy et al. (Can J Cardiol. 2023) patients will be included if categorized in Type 2, 3 or 4:
Who cannot take part
- Primary MR (e.g. papillary muscle rupture)
- EF ≤ 25%
- Accepted for CABG
- Presence of cardiogenic shock (AMR type 1)
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 99 years old?
This trial has no sites in United States.
It has sites in 4 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
To explore the impact of early transcatheter edge-to-edge repair of acute functional mitral regurgitation after myocardial infarction on the combined incidence of death and heart-failure associated hospitalisations at one-year follow-up, and quality of life and LV remodelling at two-year follow-up.
The 2 groups in the trial
- TEER + OMTTreatment being tested
Early transcatheter edge-to-edge mitral valve repair (TEER) plus optimal medical treatment
Treatment: Early transcatheter edge-to-edge mitral valve repair (TEER)., MitraClip, and Optimal medical treatment
- OMTOther group
Optimal medical treatment
Treatment: Optimal medical treatment
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Fit questions
- Built from NCT06282042, who can take part
- Record updated
- 20 October 2025